P
PentaBind utilizes Generative AI and aptamers to enhance drug discovery and diagnostics in biotechnology. The company focuses on improving the accuracy and efficiency of identifying potential therapeutic candidates and diagnostic tools, addressing the high costs and lengthy timelines associated with traditional methods.
Updated 4 months ago
Funding
$845K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- PentaBind utilizes Generative AI and aptamers to enhance drug discovery and diagnostics in biotechnology. The company focuses on improving the accuracy and efficiency of identifying potential therapeutic candidates and diagnostic tools, addressing the high costs and lengthy timelines associated with traditional methods.